Previous Close | 67.86 |
Open | 67.77 |
Bid | 67.72 x 200 |
Ask | 67.76 x 200 |
Day's Range | 67.21 - 67.82 |
52 Week Range | 64.33 - 87.87 |
Volume | |
Avg. Volume | 7,023,758 |
Market Cap | 84.369B |
Beta (5Y Monthly) | 0.23 |
PE Ratio (TTM) | 188.11 |
EPS (TTM) | 0.36 |
Earnings Date | Aug 08, 2024 |
Forward Dividend & Yield | 3.08 (4.54%) |
Ex-Dividend Date | Jun 14, 2024 |
1y Target Est | 81.29 |
SANTA MONICA, Calif., May 14, 2024--Kite, a Gilead Company (Nasdaq: GILD), today announced 12 abstracts from its industry-leading Chimeric Antigen Receptor (CAR) T-cell therapy portfolio at the upcoming 2024 European Hematology Association (EHA) Annual Congress, June 13-16, Madrid, Spain.
NORTHAMPTON, MA / ACCESSWIRE / May 14, 2024 / Olivia Sloan was pursuing a career in health policy and research when her father was diagnosed with non-Hodgkin lymphoma. The devastating news put her work on hold as she returned home to Santa Fe, New ...
S&P 500 companies have had a solid Q1 earnings season, with one key exception: drugmaker Bristol Myers Squibb.